Cargando…

In Vivo Biodistribution and Efficacy Evaluation of NeoB, A Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor

SIMPLE SUMMARY: NeoB is undergoing evaluation as a novel theragnostic agent—that is, that it can be employed either for the diagnosis of tumor expressing gastrin-releasing peptide receptor (GRPR) using nuclear imaging, or for the therapy of such GRPR positive tumors using internal radiotherapy. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montemagno, Christopher, Raes, Florian, Ahmadi, Mitra, Bacot, Sandrine, Debiossat, Marlène, Leenhardt, Julien, Boutonnat, Jean, Orlandi, Francesca, Barbato, Donato, Tedesco, Mattia, Ghezzi, Catherine, Perret, Pascale, Broisat, Alexis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958597/ https://www.ncbi.nlm.nih.gov/pubmed/33801382 http://dx.doi.org/10.3390/cancers13051051

Ejemplares similares

Side-by-side comparison of the two widely studied GRPR radiotracers, radiolabeled NeoB and RM2, in a preclinical setting
por: Damiana, T. S. T., et al.
Publicado: (2023)

TrisOxine abiotic siderophores for technetium complexation: radiolabeling and biodistribution studies
por: Leenhardt, Julien, et al.
Publicado: (2023)

Biodistribution, Stability, and Blood Distribution of the Cell Penetrating Peptide Maurocalcine in Mice
por: Perret, Pascale, et al.
Publicado: (2015)

In Vivo Assessment of VCAM-1 Expression by SPECT/CT Imaging in Mice Models of Human Triple Negative Breast Cancer
por: Montemagno, Christopher, et al.
Publicado: (2019)

NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [(67)Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice
por: Kaloudi, Aikaterini, et al.
Publicado: (2017)

Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody
por: Nachit, Maxime, et al.
Publicado: (2023)

GMP-compliant production of [(68)Ga]Ga-NeoB for positron emission tomography imaging of patients with gastrointestinal stromal tumor
por: Pretze, Marc, et al.
Publicado: (2021)

Antiproliferative activity, cell-cycle arrest, apoptotic induction and LC-HRMS/MS analyses of extracts from two Linum species
por: Mouna, Ryma, et al.
Publicado: (2022)

Safety of [(177)Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity
por: Ruigrok, Eline A. M., et al.
Publicado: (2022)

Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model
por: Lundmark, Fanny, et al.
Publicado: (2020)

Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [(11)C]Metoclopramide
por: Bauer, Martin, et al.
Publicado: (2021)

A method to improve quantitative radiotracing‐based analysis of the in vivo biodistribution of drug carriers
por: Roki, Nikša, et al.
Publicado: (2021)

Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer
por: Mitran, Bogdan, et al.
Publicado: (2019)

Mapping of brain tissue hematocrit in glioma and acute stroke using a dual autoradiography approach
por: Broisat, A., et al.
Publicado: (2018)

Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
por: Abouzayed, Ayman, et al.
Publicado: (2020)

Human biodistribution and dosimetry of [(11)C]-UCB-J, a PET radiotracer for imaging synaptic density
por: Cawthorne, Christopher, et al.
Publicado: (2021)

GRPR-targeting radiotheranostics for breast cancer management
por: D’Onofrio, Alice, et al.
Publicado: (2023)

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches
por: Verhoeven, Marjolein, et al.
Publicado: (2023)

Bioorthogonal Chemistry Approach for the Theranostics of GRPR-Expressing Cancers
por: D’Onofrio, Alice, et al.
Publicado: (2022)

Sodium-22-radiolabeled silica nanoparticles as new radiotracer for biomedical applications: in vivo positron emission tomography imaging, biodistribution, and biocompatibility
por: Al Faraj, Achraf, et al.
Publicado: (2015)

Periaortic Brown Adipose Tissue as a Major Determinant of [(18)F]-Fluorodeoxyglucose Vascular Uptake in Atherosclerosis-Prone, ApoE(−/−) Mice
por: Toczek, Jakub, et al.
Publicado: (2014)

From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma
por: Montemagno, Christopher, et al.
Publicado: (2020)

(99m)Tc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal Adenocarcinoma
por: Montemagno, Christopher, et al.
Publicado: (2019)

Pain Inhibits GRPR Neurons via GABAergic Signaling in the Spinal Cord
por: Bardoni, Rita, et al.
Publicado: (2019)

Oxytocin Elicits Itch Scratching Behavior via Spinal GRP/GRPR System
por: Guo, Jing, et al.
Publicado: (2020)

Whole-body biodistribution and radiation dosimetry of [(18)F]PR04.MZ: a new PET radiotracer for clinical management of patients with movement disorders
por: Lehnert, Wencke, et al.
Publicado: (2022)

Basic physics of radiotracers
por: Barnes, W Earl
Publicado: (2017)

GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI
por: Pu, Fan, et al.
Publicado: (2015)

The Gastrin-Releasing Peptide Receptor (GRPR) in the Spinal Cord as a Novel Pharmacological Target
por: Takanami, Keiko, et al.
Publicado: (2014)

Dose Rate Effects on the Selective Radiosensitization of Prostate Cells by GRPR-Targeted Gold Nanoparticles
por: Marques, Ana, et al.
Publicado: (2022)

Radiotracers for the Central Serotoninergic System
por: Mangeant, Reynald, et al.
Publicado: (2022)

(18)F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging
por: Yang, Min, et al.
Publicado: (2011)

Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements
por: Santos, Joana, et al.
Publicado: (2015)

Stability Evaluation and Stabilization of a Gastrin-Releasing Peptide Receptor (GRPR) Targeting Imaging Pharmaceutical
por: Ghosh, Arijit, et al.
Publicado: (2019)

Role of GRPR in Acupuncture Intervention in the “Itch-scratch Vicious Cycle” Spinal Circuit of Chronic Pruritus
por: Liu, Jia-jia, et al.
Publicado: (2023)

Decorating sdAbs with Chelators: Effect of Conjugation on Biodistribution and Functionality
por: Baudhuin, Henri, et al.
Publicado: (2021)

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy
por: Rybalov, Maxim, et al.
Publicado: (2014)

In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer
por: Bakker, Ingrid L., et al.
Publicado: (2018)

Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer
por: Abouzayed, Ayman, et al.
Publicado: (2019)

A Philosophy for CNS Radiotracer Design
por: Van de Bittner, Genevieve C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ngnmv38c7a340m67bti3vbprh3